OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: teva

Investors Interested in United Management Group, Inc.(PINKSHEETS: UYMG) Have More Questions than Answers

Posted on December 14, 2011 by Editor

It doesn’t take a lot of digging before investors uncover a number of questions concerning the operations of Unity Management Group, Inc. (PINKSHEETS: UYMG). While the company announced on Wednesday that their subsidiary, Metropolitan Computing Corporation (MCC), had sold its … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

Antares Pharma, Inc. (AMEX: AIS) Positioned to Close the Year in Big Fashion as FDA Decisions Expected in December

Posted on November 21, 2011 by Editor

The last few days have been very kind to shareholders of Antares Pharma, Inc. (AMEX: AIS) as the pharmaceutical company focusing on the development of self-injection pharmaceutical products and technologies along with topical gel-based products has received tremendous attention as … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , | Leave a comment

CEL-SCI Corporation (AMEX: CVM) Lagging as Phase III Trial for Cancer Therapy Multikine Continues to Drag

Posted on September 12, 2011 by Editor

Trying to follow the progress of CEL-SCI Corporation (AMEX: CVM) and the Phase III trial testing their cancer therapy Multikine as a treatment for newly diagnosed head and neck cancer patients can be a painful process for shareholders as the … Continue reading →

Posted in AMEX, Articles, Penny Stocks | Tagged , , , , , , , , | Leave a comment

BioSante Pharmaceuticals (NASDAQ: BPAX) Attracting Investors but FDA and Litigation Could Keep Share Price Down

Posted on August 29, 2011 by Editor

BioSante Pharmaceuticals (NASDAQ: BPAX) has been working hard to convince investors that they are on the brink of entering the $2 billion female sexual dysfunction market with their transdermal testosterone gel LibiGel, a product designed to treat hypoactive sexual desire … Continue reading →

Posted in Articles, NASDAQ, Penny Stocks | Tagged , , , , , , , , , , , | Leave a comment